Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development and provision of hemostasis and sealant technology platform. Its product candidates include AC5 Devices, which designed to achieve hemostasis during surgical, wound, and interventional care. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.
Sector:
Distribution Services
Industry:
Medical Distributors
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Arch Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Arch Therapeutics Inc market cap is $400.00.
What is the 52-week high for Arch Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Arch Therapeutics Inc 52 week high is $0.84 as of September 06, 2025.
What is the 52-week low for Arch Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Arch Therapeutics Inc 52 week low is $0.00 as of September 06, 2025.
What is Arch Therapeutics Inc stock price today?
Arch Therapeutics Inc stock price today is $2.75.
What was Arch Therapeutics Inc stock price yesterday?
Arch Therapeutics Inc stock price yesterday was $2.68.
What is the PE ratio of Arch Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Arch Therapeutics Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Arch Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Arch Therapeutics Inc P/B ratio is 0.0000.
What is the 50-day moving average of Arch Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Arch Therapeutics Inc 50-day moving average is $0.00.